ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Innovation Pharmaceuticals Inc (CE)

Innovation Pharmaceuticals Inc (CE) (IPIX)

0.0001
0.00
(0.00%)
Cerrado 21 Diciembre 3:00PM

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
0.0001
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
745,670
0.0001 Rango del Día 0.0001
0.000001 Rango de 52 semanas 0.0195
Capitalización de Mercado [m]
Precio Anterior
0.0001
Precio de Apertura
0.0001
Última hora de negociación
Volumen financiero
US$ 75
Precio Promedio Ponderado
0.0001
Volumen promedio (3 m)
348,059
Acciones en circulación
518,347,691
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
0.00
Beneficio por acción (BPA)
-0.01
turnover
-
Beneficio neto
-3.17M

Acerca de Innovation Pharmaceuticals Inc (CE)

An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its anti-cancer co... An early stage developmental biopharmaceutical company...with six pharmaceutical compound candidates that are designed for treatment of diseases which may be either existing or diseases identified in the future. The Company will initially spend most of its efforts and resources on its anti-cancer compound, Kevetrin, for the treatment of head and neck cancers. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
Sede
Carson City, Nevada, USA
Fundado
-
Innovation Pharmaceuticals Inc (CE) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker IPIX. The last closing price for Innovation Pharmaceuticals (CE) was US$0. Over the last year, Innovation Pharmaceuticals (CE) shares have traded in a share price range of US$ 0.000001 to US$ 0.0195.

Innovation Pharmaceuticals (CE) currently has 518,347,691 shares in issue. The market capitalisation of Innovation Pharmaceuticals (CE) is US$51,834.77 . Innovation Pharmaceuticals (CE) has a price to earnings ratio (PE ratio) of 0.00.

IPIX Últimas noticias

IQST Has Catalysts On Deck That Expose A Valuation Disconnect of Roughly 100% - Here's Why That Gap Should Close

November 5, 2021 -- InvestorsHub NewsWire -- via Hawk Point Media -- Benzinga iQSTEL Inc.’s (OTCQX:IQST) market cap of $62M is absurdly low. In fact, 2021 revenues, if they...

CEO Presenting on the Emerging Growth Conference on October 13 Register Now

CEO Presenting on the Emerging Growth Conference on October 13 Register Now Niche Companies in Technology, Biotech / Pharma, FinTech, Exploration, Wellness, and more in Attendance. Miami, Florida...

CEO's Presenting on the Emerging Growth Conference 17 TODAY.  Register Now

CEO's Presenting on the Emerging Growth Conference 17 TODAY.  Register Now   Niche Companies in Technology, Biotech / Pharma, FinTech, Exploration, Wellness, and more in...

CLS Holdings, (OTCQB: CLSH) New Joint Venture $19 million Sales 61% Growth

CLS Holdings, (OTCQB: CLSH) New Joint Venture $19 million Sales 61% Growth   Miami, FL--(September 28, 2021) – EmergingGrowth.com, a leading independent small cap media portal...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.0002-66.66666666670.00030.00030.00012280840.00026697CS
4-0.0001-500.00020.01860.00011626520.00029274CS
12-0.0002-66.66666666670.00030.01870.00013480590.00040829CS
26-0.0011-91.66666666670.00120.01871.0E-62618610.00044554CS
52-0.0049-980.0050.01951.0E-64163270.00669418CS
156-0.0593-99.83164983160.05940.06491.0E-65433740.02411051CS
260-0.0649-99.84615384620.0650.651.0E-612868680.16916523CS

IPIX - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Innovation Pharmaceuticals (CE)?
El precio actual de las acciones de Innovation Pharmaceuticals (CE) es US$ 0.0001
¿Cuántas acciones de Innovation Pharmaceuticals (CE) están en circulación?
Innovation Pharmaceuticals (CE) tiene 518,347,691 acciones en circulación
¿Cuál es la capitalización de mercado de Innovation Pharmaceuticals (CE)?
La capitalización de mercado de Innovation Pharmaceuticals (CE) es USD 51.83k
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Innovation Pharmaceuticals (CE)?
Innovation Pharmaceuticals (CE) ha negociado en un rango de US$ 0.000001 a US$ 0.0195 durante el último año
¿Cuál es la moneda de reporte de Innovation Pharmaceuticals (CE)?
Innovation Pharmaceuticals (CE) presenta sus resultados financieros en USD
¿Cuál es el último beneficio anual de Innovation Pharmaceuticals (CE)?
El último beneficio anual de Innovation Pharmaceuticals (CE) es USD -3.17M
¿Cuál es la dirección registrada de Innovation Pharmaceuticals (CE)?
La dirección registrada de Innovation Pharmaceuticals (CE) es 701 S. CARSON STREET, SUITE 200, CARSON CITY, NEVADA, 89701
¿Cuál es la dirección del sitio web de Innovation Pharmaceuticals (CE)?
La dirección del sitio web de Innovation Pharmaceuticals (CE) es www.ipharminc.com
¿En qué sector industrial opera Innovation Pharmaceuticals (CE)?
Innovation Pharmaceuticals (CE) opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ELIQQElectriq Power Holdings Inc (CE)
US$ 0.10
(99,900.00%)
100
GNTLFGenetic Technologies Ltd (PK)
US$ 1.00
(90,809.09%)
100
VIVEViveve Medical Inc (CE)
US$ 0.0003
(29,900.00%)
7.33k
BTIMBoatim Inc (CE)
US$ 0.0002
(19,900.00%)
799
CLVRClever Leaves Holdings Inc (CE)
US$ 0.0002
(19,900.00%)
592
RAASYCloopen Group Holding Limited (CE)
US$ 0.000001
(-100.00%)
214
EWGFFEat Well Investment Group Inc (CE)
US$ 0.000001
(-100.00%)
47.01k
SOLBFSoLVBL Solutions Inc (CE)
US$ 0.000001
(-99.99%)
10k
HAVLFHavn Life Sciences Inc (CE)
US$ 0.000001
(-99.98%)
4.02k
ENDRFEndor AG (GM)
US$ 0.0001
(-99.98%)
560
HMBLHUMBL Inc (PK)
US$ 0.00095
(5.56%)
344.89M
PHILPHI Group Inc (PK)
US$ 0.0003
(0.00%)
312.21M
PLPLPlandai Biotechnology Inc (PK)
US$ 0.0001
(0.00%)
215.71M
RDARRaadr Inc (PK)
US$ 0.0014
(16.67%)
174.96M
CHNVFChina Youzan Ltd (PK)
US$ 0.0177
(10.63%)
100M

IPIX Discussion

Ver más
zandant zandant 4 horas hace
LOL. Looks like the Ehrlich was "laser focused" as far back as 2016. Unfortunately, nothing but false hope, failures and hype that never materialized. Too bad he wasn't laser focused on the lease agreement that should be the final nail in the IPIX coffin....
"Looking ahead to 2017, we intend to remain laser focused on advancing our clinical pipeline with concurrent nurturing of relationships that can potentially lead to partnerships."
👍️0
TheHound TheHound 9 horas hace
News! https://www.globenewswire.com/fr/news-release/2016/12/22/901271/0/en/Cellceutix-Wishes-Shareholders-Happy-Holidays-Prepares-for-2017-Focused-on-Partnerships.html




Albeit old news. Very old news.
👍️0
williamssc williamssc 2 días hace
I doubt Leo wants the government looking at his books. What we need is sunlight.
👍️0
loanranger loanranger 2 días hace
"Big Z, we have no idea what he's doing behind the scenes"
Sure we do....he's out helping OJ find the real killers.
👍️ 1
PJ007 PJ007 3 días hace
Big Z, we have no idea what he's doing behind the scenes.....as a long time shareholder, i believe he owes it to his shareholder's to tell us.......
👍 1
zandant zandant 3 días hace
Reading your post, I thought it was April 1st instead of December 18th. Do you really think Ehrlich would lift a finger (other than the middle finger towards the shareholders) to pull this mess out of the gutter? He has abandoned what is left of his one-man operation just like he abandoned the shareholders long ago.
👍️0
PJ007 PJ007 4 días hace
Why can't IPIX receive a similar grant for Brilacidin with all the studies that have taken place. I really hope that Leo has applied for one!!!!!
https://finance.yahoo.com/news/marker-therapeutics-awarded-9-5-120000070.html
👍️ 1
realscottsmith realscottsmith 1 semana hace
The grave just happens to be sunbathing with a fruity drink poolside in Boca.
👍️ 1
JTORENCE JTORENCE 1 semana hace
The headstone has been ordered, just waiting for delivery and the crew to show up to place it on the grave. "RIP" IPIX, you have taken peoples had earned dollars to the grave with you.
👍️0
zandant zandant 2 semanas hace
And once the Court of Appeal decision comes down, it will finally be buried.
👍 1
TheHound TheHound 2 semanas hace
IPIX is dead!
👍️0
sunspotter sunspotter 2 semanas hace
Nope. He sleeps like a baby in a feather bedded mattress that IPIX shareholders paid for.

When he’s not lounging by his Florida mansion’s pool, that is.
👍️0
JTORENCE JTORENCE 2 semanas hace
zandant Hopefully he now sleeps with the "fishes"
👍️0
threebabiesbusy threebabiesbusy 2 semanas hace
What a putz!
👍️ 1
zandant zandant 2 semanas hace
The CEO has also gone missing.....
👍️0
threebabiesbusy threebabiesbusy 2 semanas hace
Missing the group of long timers.
👍️0
duchamp duchamp 2 semanas hace
Truly disheartening!
👍️0
sunspotter sunspotter 2 semanas hace
He hasn't posted for a while:

https://investorshub.advfn.com/boards/profileb.aspx?user=70157

Which is a shame.
👍️0
threebabiesbusy threebabiesbusy 2 semanas hace
Minnie are you still around?
👍️0
threebabiesbusy threebabiesbusy 2 semanas hace
Hopefully when we least expect it!
👍️ 1
zandant zandant 2 semanas hace
Will anyone ever hear from Ehrlich again?
👍️0
zandant zandant 2 semanas hace
Point your anger over what must be a significant loss at Ehrlich, "dude." Still believing that this garbage is hidden treasure is what's truly sick.
👍️0
threebabiesbusy threebabiesbusy 2 semanas hace
Will this ever come back to life? hmmmmm
👍️0
PJ007 PJ007 2 semanas hace
Dude, the posts by you guys are pathetic. Why are you so concerned about my investment or any one else's.....this is borderline sick.....
💯 1
zandant zandant 2 semanas hace
Why do you care about a poster on a message board? Maybe you should focus on your hero Ehrlich and find out where he is and ask him why you have lost your investment. Ask him what happened with the Laser Boys big laser beam splash.
👍️ 1
sunspotter sunspotter 2 semanas hace
“ $4 million wasted on the Laser Boys should be on Ehrlich's failed company's virtual headstone”

I suspect you’ll find a goodly portion of that $4 million poolside at Ehrlich’s Florida mansion.
👍️0
PJ007 PJ007 2 semanas hace
We get it, IPIX is dead, Ehrlich is a crook. Why do you guys keep coming here???? I don't get it.....
👍️0
zandant zandant 2 semanas hace
Even Ehrlich, the biggest lying hypster around, has abandoned this sunken ship. Once the appeal is lost, the bones of IPIX will turn to dust...and the $4 million wasted on the Laser Boys should be on Ehrlich's failed company's virtual headstone.
👍️ 1
sunspotter sunspotter 3 semanas hace
“Quite a shame”

But utterly predictable. Indeed utterly predicted.
👍️0
1oldprof 1oldprof 3 semanas hace
I cannot believe there are still people in this stock. This company is dead. Quite a shame, really
👍️ 1
TheHound TheHound 3 semanas hace
The one question…. LOL. Fuck no. U know that. Shit. Core shares here when I sold just before the release of the COVID results were invested in bitcoin/alt/meme coins. I 10x that and am currently up 5x this bull run which is just getting started. This shit is and will always be chump change compared to crypto.

Poor bastards. Shake that bag.
👍️0
loanranger loanranger 3 semanas hace
I still have mine!
👍️0
leavetheguntakethecannolis leavetheguntakethecannolis 3 semanas hace
The one question that results in silence. Blissful silence.
👍 2 😂 1
PJ007 PJ007 3 semanas hace
Hey Hound, as per your old posts, you were a huge investor???? Do you still own your shares?????
👍 1 😄 1
TheHound TheHound 3 semanas hace
While we wait…Any new B-Petri dish papers published lately?

Petri dish studies, also known as in vitro experiments, often lead to false hope because they are conducted in highly controlled laboratory environments that do not fully replicate the complexity of living organisms. Here are the key reasons for this:

1. Oversimplified Conditions
In a Petri dish, cells are isolated and grown in artificial environments with carefully controlled nutrients, pH, and temperature. This does not mimic the intricate systems and interactions that occur in a living organism. A treatment that works on isolated cells may behave very differently in the body.

2. Lack of Systemic Factors
The body is a dynamic system with multiple interacting components, including the immune system, hormones, and metabolism. A treatment might show promise in a Petri dish but fail when introduced to the complexities of a whole organism.

3. Doses and Delivery
In in vitro studies, substances can be applied directly to cells at specific concentrations. In the body, reaching the target cells in the same way can be much more difficult due to issues with absorption, distribution, metabolism, and excretion.

4. Overextrapolation
Positive results in in vitro studies are sometimes overhyped in the media or even by researchers, leading to unrealistic expectations about how soon a discovery might lead to effective treatments for humans.

5. Lack of Whole-Body Toxicity Data
A compound might kill harmful cells in a Petri dish but could be toxic to normal cells or organs in a living organism. The safety profile often cannot be assessed until in vivo studies (in animals or humans) are conducted.

Example

Many cancer drugs have shown promise in killing tumor cells in a Petri dish but fail in clinical trials due to poor efficacy in the body or unacceptable side effects. Similarly, certain antioxidants or supplements that protect cells in in vitro studies have not demonstrated significant health benefits when tested in humans.

Conclusion

While Petri dish studies are valuable for initial insights and screening, they are only the first step in a long process of research. Their findings must be validated through animal studies, human trials, and real-world applications before they can lead to effective and safe treatments.

Universities publish a significant amount of research involving Petri dishes (in vitro studies) because these experiments are foundational to scientific inquiry and serve important purposes in advancing knowledge and innovation. Here’s why:

1. Early-Stage Discovery

• In vitro studies are often the first step in investigating new ideas, testing hypotheses, and identifying potential mechanisms in biology and medicine.

• They provide a cost-effective and controlled way to test theories before advancing to more complex and expensive animal or human studies.

2. Building a Knowledge Base

• Universities prioritize generating fundamental knowledge, even if it doesn’t immediately lead to clinical applications.

• Petri dish studies contribute valuable insights into how cells, molecules, and organisms work at a basic level.

3. Low-Risk and Ethical Feasibility

• Using Petri dishes avoids ethical and logistical complications involved in animal or human studies.

• Early-stage research involving living organisms requires more rigorous oversight and approval, making in vitro studies an accessible starting point.

4. Funding and Academic Metrics

• Grant agencies often fund exploratory research to develop preliminary data for larger projects. Petri dish studies are a common source of this early data.

• Academic researchers are often measured by their publication output, so publishing in vitro findings helps meet performance and funding expectations.

5. Proof of Concept

• Researchers use Petri dish experiments to show whether an idea has potential. These results can justify follow-up studies in animals or humans, securing further funding or collaboration.

• Journals often accept such studies because they are a crucial step in the pipeline of scientific discovery.

6. Incremental Nature of Science

• Science progresses in small, incremental steps. Petri dish studies often represent one of these steps in understanding complex biological phenomena.

• Even if a study doesn’t lead directly to a cure or breakthrough, it may provide a building block for future discoveries.

7. Ease of Reproducibility

• Petri dish studies are typically easier to replicate compared to animal or human studies, making them valuable for establishing reproducible science.

Challenges and Context

While universities publish a lot of Petri dish research, it is essential for scientists, journals, and the media to clearly communicate the limitations of such studies. Misrepresentation of preliminary findings as groundbreaking breakthroughs can lead to false hope, but this is not inherent to the research itself—it’s often a matter of how the results are presented or interpreted.
👍️0
loanranger loanranger 4 semanas hace
IPIX has until 1/19 to respond to the Cummings brief filed on 11/12.
Unfortunately we don't get to see what these briefs say.

This is the last hard fact I've seen...from the original case:
"08/23/2024 ORDER: of Post Judgment Security
..II. ALTERNATIVE SECURITY
In accordance with General Laws c. 223, sec. 86A, Innovation shall obtain and provide within thirty (30) days of this Order a bond payment to Cummings with sureties to be approved by this Court conditioned to pay Cummings the amount of at least $1,375,811.36, within thirty (30) days of the date when execution may issue upon judgment, which bond shall be filed with the clerk after its approval by the Court."

Would be interesting to know if that was done....I thought the appeal was contingent on it.
👍️ 2
Cassius Longinus Cassius Longinus 4 semanas hace
Now delayed until January 19th?
👍️0
TheHound TheHound 4 semanas hace
oooooooooooooooooo2 x 0 is zero. It’s dead.
👍️0
AKBrakeman AKBrakeman 4 semanas hace
We're holding at .oooooooooooooooooo2.  Not dead yet! 
👍 1
TheHound TheHound 4 semanas hace
IPIX is dead. Not trading. Zero value.

4 trillion shares traded TODAY so far. 1/4 Billion dollars. Dump the remaining buck left in your bag and make100x ur money for a $100 steak dinner at Outback! Hell! I’m buyin. Let’s go!

Poor bastards.

👍️0
TheHound TheHound 4 semanas hace
LOL. Shake that bag.
👍️0
PJ007 PJ007 1 mes hace
I have to admit that I agree with you!!!!!!
👍 1
loanranger loanranger 1 mes hace
"he's due to update his shareholders....."

What a ridiculous comment. Due? He's been OBLIGATED to update his shareholders (and everyone else) since the 10Q that was filed A YEAR AGO yesterday and he hasn't.
He continues to show himself to be irresponsible at the very least....crooked is probably more fitting.

You're lucky you haven't heard from him. It would only add fuel to your misguided beliefs.
👍️ 4
PJ007 PJ007 1 mes hace
I'd rather hear from Leo, he's due to update his shareholders.....
👍️0
MackG MackG 1 mes hace
Absolutely, unless it's a quiet period that has been dragging on. I would love to hear from frenchbroad right about now.
👍 1
PJ007 PJ007 1 mes hace
That's a great question that only Leo can answer. I really wish he would address his shareholders......
👍 1
MackG MackG 1 mes hace
Has or will IPIX be compensated by the... many companies who have included Brilacidin in their patent applications?
Have these companies entered into compensation arrangements or agreements with IPIX?
Can anyone knowledgable in this area enlighten me? TIA
👍 2
MackG MackG 1 mes hace
Brilacidin has been included in many patent applications. Have these companies done this after entering into compensation arrangements or agreements with IPIX?
Can anyone knowledgable in this area enlighten me? TIA
👍 1
TheHound TheHound 1 mes hace
Shake that bag.
👍️ 1
leavetheguntakethecannolis leavetheguntakethecannolis 1 mes hace
IPIX isn't dead.
👍 2

Su Consulta Reciente

Delayed Upgrade Clock